123 related articles for article (PubMed ID: 23141783)
1. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.
Casadio V; Calistri D; Tebaldi M; Bravaccini S; Gunelli R; Martorana G; Bertaccini A; Serra L; Scarpi E; Amadori D; Silvestrini R; Zoli W
Urol Oncol; 2013 Nov; 31(8):1744-50. PubMed ID: 23141783
[TBL] [Abstract][Full Text] [Related]
2. Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.
Salvi S; Gurioli G; Martignano F; Foca F; Gunelli R; Cicchetti G; De Giorgi U; Zoli W; Calistri D; Casadio V
Dis Markers; 2015; 2015():574120. PubMed ID: 26412928
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA Integrity Analysis in Urine Samples.
Casadio V; Salvi S; Martignano F; Gunelli R; Ravaioli S; Calistri D
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117781
[TBL] [Abstract][Full Text] [Related]
4. Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.
Casadio V; Calistri D; Salvi S; Gunelli R; Carretta E; Amadori D; Silvestrini R; Zoli W
Biomed Res Int; 2013; 2013():270457. PubMed ID: 23509700
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
Zancan M; Galdi F; Di Tonno F; Mazzariol C; Orlando C; Malentacchi F; Agostini M; Maran M; Del Bianco P; Fabricio AS; Murer B; Pianon C; Gion M
Int J Biol Markers; 2009; 24(3):147-55. PubMed ID: 19787625
[TBL] [Abstract][Full Text] [Related]
6. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
[TBL] [Abstract][Full Text] [Related]
7. UPK3A: a promising novel urinary marker for the detection of bladder cancer.
Lai Y; Ye J; Chen J; Zhang L; Wasi L; He Z; Zhou L; Li H; Yan Q; Gui Y; Cai Z; Wang X; Guan Z
Urology; 2010 Aug; 76(2):514.e6-11. PubMed ID: 20346489
[TBL] [Abstract][Full Text] [Related]
8. Detection of bladder cancer by measuring CD44v6 expression in urine with real-time quantitative reverse transcription polymerase chain reaction.
Hattori S; Kojima K; Minoshima K; Yamaha M; Horie M; Sawamura T; Kikuchi A; Deguchi T
Urology; 2014 Jun; 83(6):1443.e9-15. PubMed ID: 24726313
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
11. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
12. LASP-1, a novel urinary marker for detection of bladder cancer.
Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
14. Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer.
Scher MB; Elbaum MB; Mogilevkin Y; Hilbert DW; Mydlo JH; Sidi AA; Adelson ME; Mordechai E; Trama JP
J Urol; 2012 Dec; 188(6):2101-7. PubMed ID: 23083854
[TBL] [Abstract][Full Text] [Related]
15. Urinary cell-free DNA as a potential tumor marker for bladder cancer.
Chang HW; Tsui KH; Shen LC; Huang HW; Wang SN; Chang PL
Int J Biol Markers; 2007; 22(4):287-94. PubMed ID: 18161660
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
Sánchez-Carbayo M; Herrero E; Megias J; Mira A; Espasa A; Chinchilla V; Soria F
J Urol; 1999 Apr; 161(4):1110-5. PubMed ID: 10081849
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
18. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
19. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M
Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254
[TBL] [Abstract][Full Text] [Related]
20. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
